Answers are grounded in this paper and cite their sources.
PURPOSE: To assess delayed epithelialization and corneal haze related to nepafenac ophthalmic suspension 0.1% (Nevanac) use after photorefractive keratectomy (PRK). SETTING: Private practice, Beverly Hills, California, USA. METHODS: This retrospective comparative chart review comprised 69 eyes (44 patients) that were divided into 2 treatment groups that were not statistically significantly different in age or preoperative spherical equivalent. The nepafenac group consisted of 34 eyes (22 patients) that received nepafenac 0.1%, moxifloxacin, and fluorometholone postoperatively. The non-nepafenac group included 35 eyes (22 patients) that received moxifloxacin and fluorometholone only. Patients were seen between 1 day and 5 days postoperatively for evaluation of epithelial healing and haze formation. Delayed epithelialization was defined as healing after day 5. All patients were followed for haze formation for a minimum of 3 months. RESULTS: Statistical analysis showed no difference between the nepafenac and non-nepafenac groups in delayed epithelialization (P = .61, chi-square test). Neither group had significant corneal haze. CONCLUSION: Nepafenac did not appear to delay corneal epithelial healing or contribute to haze formation after PRK.
No takes yet. Share an insight, caveat, or question.
Jalali et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: